Raymond-James-Financial

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
12,351
Total Value
228341987656
Accession Number
0000720005-25-000054
Form Type
13F-HR
Manager Name
Raymond-James-Financial
Data Enrichment
71% identified
8,792 identified3,559 unidentified

Holdings

12,351 positions • $228.3B total value
Manager:
Search and click to pin securities to the top
Solid Power, Inc.
Shares:17.8K
Value:$18.6K
% of Portfolio:0.0% ($18.6K/$228.3B)
RESEARCH FRONTIERS INC
Shares:16.4K
Value:$18.6K
% of Portfolio:0.0% ($18.6K/$228.3B)
Fathom Holdings Inc.
Shares:20.7K
Value:$18.3K
% of Portfolio:0.0% ($18.3K/$228.3B)
DURECT CORP
Shares:22.7K
Value:$18.2K
% of Portfolio:0.0% ($18.2K/$228.3B)
477839AB0
Shares:—
Value:$18.0K
% of Portfolio:0.0% ($18.0K/$228.3B)
SMITH MICRO SOFTWARE, INC.
Shares:24.4K
Value:$17.9K
% of Portfolio:0.0% ($17.9K/$228.3B)
Q32 Bio Inc.
Shares:10.7K
Value:$17.7K
% of Portfolio:0.0% ($17.7K/$228.3B)
T1 Energy Inc.
Shares:13.7K
Value:$17.3K
% of Portfolio:0.0% ($17.3K/$228.3B)
Flux Power Holdings, Inc.
Shares:10.0K
Value:$17.2K
% of Portfolio:0.0% ($17.2K/$228.3B)
Viomi Technology Co., Ltd
Shares:10.9K
Value:$17.0K
% of Portfolio:0.0% ($17.0K/$228.3B)
WM TECHNOLOGY, INC.
Shares:14.9K
Value:$16.9K
% of Portfolio:0.0% ($16.9K/$228.3B)
FibroBiologics, Inc.
Shares:18.6K
Value:$16.8K
% of Portfolio:0.0% ($16.8K/$228.3B)
PDS Biotechnology Corp
Shares:14.0K
Value:$16.6K
% of Portfolio:0.0% ($16.6K/$228.3B)
OLAPLEX HOLDINGS, INC.
Shares:13.0K
Value:$16.6K
% of Portfolio:0.0% ($16.6K/$228.3B)
09061GAK7
Shares:—
Value:$16.0K
% of Portfolio:0.0% ($16.0K/$228.3B)
00971TAJ0
Shares:—
Value:$15.9K
% of Portfolio:0.0% ($15.9K/$228.3B)
Trilogy Metals Inc.
Shares:10.0K
Value:$15.6K
% of Portfolio:0.0% ($15.6K/$228.3B)
FRACTYL HEALTH, INC.
Shares:12.8K
Value:$15.2K
% of Portfolio:0.0% ($15.2K/$228.3B)
Microvast Holdings, Inc.
Shares:13.0K
Value:$15.2K
% of Portfolio:0.0% ($15.2K/$228.3B)
ROCKWELL MEDICAL, INC.
Shares:13.4K
Value:$15.1K
% of Portfolio:0.0% ($15.1K/$228.3B)